Abstract
Vaccinology has come a long way from early, empirically developed vaccines to modern vaccines rationally designed and produced. Vaccines are meant to cooperate with the human immune system, the later largely unknown in the early years of vaccine development. In the recent years, a tremendous depth of knowledge has been accumulated in the field of immunology that has provided an opportunity to understand the mechanisms of action of the vaccine components. In parallel, our knowledge in microbiology, molecular biology, infectiology, epidemiology, and furthermore in bioinformatics has fostered our understanding of the interaction of microorganisms with the human immune system. Strategies engaged by pathogens strongly determine the targets of a vaccine, which should be formulated to stimulate potent and efficiently protective immune responses. The improved knowledge of immune response mechanisms has facilitated the development of new vaccines with the capacity to selectively address the key pathogenic mechanisms. The primary goal of a vaccine design might no longer be to mimic the pathogen but to identify the relevant processes of the pathogenic mechanisms to be effectively interrupted by a highly specific immune response, eventually surpassing natural limitations. Vaccines have become complex sets of components meant to orchestrate the fine-tuning of the immune processes leading to a lasting and specific immune memory. In addition to antigenic materials, which are comprised of the most critical immunogenic epitopes, adjuvant components are frequently added to induce a favorable immunological activation. Furthermore, for reasons of production and product stability preservatives, stabilizers, inactivators, antibiotics, or diluents could be present, but need to be evaluated. While on the one hand vaccine effectiveness is a primary goal, on the other hand side effects need to be excluded due to safety and tolerability. Further challenges in vaccinology include variability of the vaccinees, the variability of the pathogen, the population-based settings of vaccine application, and the process technology in vaccine production. Vaccine design has become more tailored and in turn has opened up the potential of extending its application to hitherto not accessible complex microbial pathogens plus providing new immunotherapies to tackle diseases such as cancer, Alzheimer’s disease, and autoimmune disease. This chapter gives an overview of the key considerations and processes involved in vaccine design and development. It also describes the basic principles of normal immune responses and in their function in defense of infectious agents by vaccination.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Plotkin S (2014) History of vaccination. Proc Natl Acad Sci U S A 111(34):12283–12287. https://doi.org/10.1073/pnas.1400472111
Buck C (2003) Smallpox inoculation—should we credit Chinese medicine? Complement Ther Med 11(3):201–202. https://doi.org/10.1016/S0965-2299(03)00087-6
Rappuoli R, Bottomley MJ, D’Oro U, Finco O, De Gregorio E (2016) Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design. J Exp Med 213(4):469–481. https://doi.org/10.1084/jem.20151960
Raeven RHM, van Riet E, Meiring HD, Metz B, Kersten GFA (2019) Systems vaccinology and big data in the vaccine development chain. Immunology 156(1):33–46. https://doi.org/10.1111/imm.13012
Wimmers F, Pulendran B (2020) Emerging technologies for systems vaccinology — multi-omics integration and single-cell (epi)genomic profiling. Curr Opin Immunol 65:57–64. https://doi.org/10.1016/j.coi.2020.05.001
Del Giudice G, Rappuoli R, Didierlaurent AM (2018) Correlates of adjuvanticity: a review on adjuvants in licensed vaccines. Semin Immunol 39:14–21. https://doi.org/10.1016/j.smim.2018.05.001
Hussein IH (2015) Vaccines through centuries: major cornerstones of global health. Front Public Health 3:269. https://doi.org/10.3389/fpubh.2015.00269
Minor PD (2015) Live attenuated vaccines: historical successes and current challenges. Virology 479–480:379–392. https://doi.org/10.1016/j.virol.2015.03.032
Orme IM (2015) Tuberculosis vaccine types and timings. Clin Vaccine Immunol 22(3):249–257. https://doi.org/10.1128/CVI.00718-14
Villarreal R, Casale TB (2020) Commonly used adjuvant human vaccines: advantages and side effects. J Allergy Clin Immunol Pract S2213219820304025. https://doi.org/10.1016/j.jaip.2020.04.045
Zepp F (2010) Principles of vaccine design—Lessons from nature. Vaccine 28:C14–C24. https://doi.org/10.1016/j.vaccine.2010.07.020
Poland GA, Ovsyannikova IG, Kennedy RB (2018) Personalized vaccinology: a review. Vaccine 36(36):5350–5357. https://doi.org/10.1016/j.vaccine.2017.07.062
Savage N (2019) Arming the immune system. Nature 575(7784):S44–S45. https://doi.org/10.1038/d41586-019-03636-8
Gasteiger G, D’Osualdo A, Schubert DA, Weber A, Bruscia EM, Hartl D (2017) Cellular innate immunity: an old game with new players. J Innate Immun 9(2):111–125. https://doi.org/10.1159/000453397
Netea MG, Schlitzer A, Placek K, Joosten LAB, Schultze JL (2019) Innate and adaptive immune memory: an evolutionary continuum in the host’s response to pathogens. Cell Host Microb 25(1):13–26. https://doi.org/10.1016/j.chom.2018.12.006
Placek K, Schultze JL, Netea MG (2019) Immune memory characteristics of innate lymphoid cells. Curr Opin Infect Dis 32(3):196–203. https://doi.org/10.1097/QCO.0000000000000540
Zheng C (2020) Protein dynamics in cytosolic DNA-sensing antiviral innate immune signaling pathways. Front Immunol 11:1255. https://doi.org/10.3389/fimmu.2020.01255
Uehata T, Takeuchi O (2020) RNA recognition and immunity—innate immune sensing and its posttranscriptional regulation mechanisms. Cells 9(7):1701. https://doi.org/10.3390/cells9071701
Kumar H, Kawai T, Akira S (2011) Pathogen recognition by the innate immune system. Int Rev Immunol 30(1):16–34. https://doi.org/10.3109/08830185.2010.529976
Raymond SL (2017) Microbial recognition and danger signals in sepsis and trauma. Biochim Biophys Acta Mol Basis Dis 1863(10):2564–2573. https://doi.org/10.1016/j.bbadis.2017.01.013
Schmidt C, Schneble N, Wetzker R (2014) The fifth dimension of innate immunity. J Cell Commun Signal 8(4):363–367. https://doi.org/10.1007/s12079-014-0246-6
Włodarczyk M, Druszczyńska M, Fol M (2019) Trained innate immunity not always amicable. IJMS 20(10):2565. https://doi.org/10.3390/ijms20102565
Riera Romo M, PĂ©rez-MartĂnez D, Castillo Ferrer C (2016) Innate immunity in vertebrates: an overview. Immunology 148(2):125–139. https://doi.org/10.1111/imm.12597
Carroll MC, Isenman DE (2012) Regulation of humoral immunity by complement. Immunity 37(2):199–207. https://doi.org/10.1016/j.immuni.2012.08.002
Sánchez-Ramón S, Conejero L, Netea MG, Sancho D, Palomares Ó, Subiza JL (2018) Trained immunity-based vaccines: a new paradigm for the development of broad-spectrum anti-infectious formulations. Front Immunol 9:2936. https://doi.org/10.3389/fimmu.2018.02936
Collin M, Ginhoux F (2019) Human dendritic cells. Semin Cell Dev Biol 86:1–2. https://doi.org/10.1016/j.semcdb.2018.04.015
Bieber K, Autenrieth SE (2020) Dendritic cell development in infection. Mol Immunol 121:111–117. https://doi.org/10.1016/j.molimm.2020.02.015
Arstila TP (1999) A direct estimate of the human T cell receptor diversity. Science 286(5441):958–961. https://doi.org/10.1126/science.286.5441.958
Miles JJ, Douek DC, Price DA (2011) Bias in the αβ T-cell repertoire: implications for disease pathogenesis and vaccination. Immunol Cell Biol 89(3):375–387. https://doi.org/10.1038/icb.2010.139
KĂĽnzli M (2020) Long-lived T follicular helper cells retain plasticity and help sustain humoral immunity. Sci Immunol 5(45):eaay5552. https://doi.org/10.1126/sciimmunol.aay5552
Jameson SC, Masopust D (2018) Understanding subset diversity in T cell memory. Immunity 48(2):214–226. https://doi.org/10.1016/j.immuni.2018.02.010
Akkaya M, Kwak K, Pierce SK (2020) B cell memory: building two walls of protection against pathogens. Nat Rev Immunol 20(4):229–238. https://doi.org/10.1038/s41577-019-0244-2
Eibel H, Kraus H, Sic H, Kienzler A-K, Rizzi M (2014) B cell biology: an overview. Curr Allergy Asthma Rep 14(5):434. https://doi.org/10.1007/s11882-014-0434-8
Inoue T, Moran I, Shinnakasu R, Phan TG, Kurosaki T (2018) Generation of memory B cells and their reactivation. Immunol Rev 283(1):138–149. https://doi.org/10.1111/imr.12640
Gray JI, Westerhof LM, MacLeod MKL (2018) The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination. Immunology 154(4):574–581. https://doi.org/10.1111/imm.12929
Davis ASW (2019) The human tissue-resident CCR5+ T cell compartment maintains protective and functional properties during inflammation. Sci Transl Med 11(521):eaaw8718. https://doi.org/10.1126/scitranslmed.aaw8718
Morrot A (2017) Human stem memory T cells (TSCM) as critical players in the long-term persistence of immune responses. Ann Transl Med 5(5):120. https://doi.org/10.21037/atm.2017.02.28
Schumacher TN, Scheper W, Kvistborg P (2019) Cancer neoantigens. Annu Rev Immunol 37(1):173–200. https://doi.org/10.1146/annurev-immunol-042617-053402
Thakur A, Pedersen LE, Jungersen G (2012) Immune markers and correlates of protection for vaccine induced immune responses. Vaccine 30(33):4907–4920. https://doi.org/10.1016/j.vaccine.2012.05.049
Pennock ND, Kedl JD, Kedl RM (2016) T cell vaccinology: beyond the reflection of infectious responses. Trends Immunol 37(3):170–180. https://doi.org/10.1016/j.it.2016.01.001
Yost KE, Chang HY, Satpathy AT (2020) Tracking the immune response with single-cell genomics. Vaccine 38(28):4487–4490. https://doi.org/10.1016/j.vaccine.2019.11.035
Josefsberg JO, Buckland B (2012) Vaccine process technology. Biotechnol Bioeng 109(6):1443–1460. https://doi.org/10.1002/bit.24493
Vetter V, Denizer G, Friedland LR, Krishnan J, Shapiro M (2018) Understanding modern-day vaccines: what you need to know. Ann Med 50(2):110–120. https://doi.org/10.1080/07853890.2017.1407035
Nakayama T (2019) Causal relationship between immunological responses and adverse reactions following vaccination. Vaccine 37(2):366–371. https://doi.org/10.1016/j.vaccine.2018.11.045
Maertzdorf J, Kaufmann SHE, Weiner J (2015) Molecular signatures for vaccine development. Vaccine 33(40):5256–5261. https://doi.org/10.1016/j.vaccine.2015.03.075
Kocourkova A, Honegr J, Kuca K, Danova J (2017) Vaccine ingredients: components that influence vaccine efficacy. Mini Rev Med Chem 17(5):451–466. https://doi.org/10.2174/1389557516666160801103303
Wang YB, Wang LP, Li P (2018) Perspectives on novel vaccine development. Pol J Vet Sci 21(3):643–649. https://doi.org/10.24425/124302
Orlando R (2015) Prevention of hepatitis B virus infection: from the past to the future. Eur J Clin Microbiol Infect Dis 34(6):1059–1070. https://doi.org/10.1007/s10096-015-2341-x
Kapil P, Merkel TJ (2019) Pertussis vaccines and protective immunity. Curr Opin Immunol 59:72–78. https://doi.org/10.1016/j.coi.2019.03.006
Meyer CU (2007) Cellular immunity in adolescents and adults following acellular pertussis vaccine administration. Clin Vaccine Immunol 14(3):288–292. https://doi.org/10.1128/CVI.00364-06
Mohsen MO, Zha L, Cabral-Miranda G, Bachmann MF (2017) Major findings and recent advances in virus–like particle (VLP)-based vaccines. Semin Immunol 34:123–132. https://doi.org/10.1016/j.smim.2017.08.014
Houser K, Subbarao K (2015) Influenza vaccines: challenges and solutions. Cell Host Microb 17(3):295–300. https://doi.org/10.1016/j.chom.2015.02.012
Huijts SM, Coenjaerts FEJ, Bolkenbaas M, van Werkhoven CH, Grobbee DE, Bonten MJM (2018) The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly. Clin Microbiol Infection 24(7):764–770. https://doi.org/10.1016/j.cmi.2017.10.006
Borrow R, Dagan R, Zepp F, Hallander H, Poolman J (2011) Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules. Expert Rev Vaccines 10(11):1621–1631. https://doi.org/10.1586/erv.11.142
Kennedy RB, Ovsyannikova IG, Palese P, Poland GA (2020) Current challenges in vaccinology. Front Immunol 11:1181. https://doi.org/10.3389/fimmu.2020.01181
Van Den Ende C, Marano C, Van Ahee A, Bunge EM, De Moerlooze L (2017) The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience. Expert Rev Vaccines 16(8):811–832. https://doi.org/10.1080/14760584.2017.1338568
Kiyotani K, Toyoshima Y, Nemoto K, Nakamura Y (2020) Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2. J Hum Genet 65(7):569–575. https://doi.org/10.1038/s10038-020-0771-5
Kis Z, Shattock R, Shah N, Kontoravdi C (2018) Emerging technologies for low-cost, rapid vaccine manufacture. Biotechnol J 14:e1800376. https://doi.org/10.1002/biot.201800376
WHO (2020) Vaccines and diseases. https://www.who.int/immunization/diseases/en/
Rauch S, Jasny E, Schmidt KE, Petsch B (2018) New vaccine technologies to combat outbreak situations. Front Immunol 9:1963. https://doi.org/10.3389/fimmu.2018.01963
Patel A, Kaufman HL, Disis ML (2017) Next generation approaches for tumor vaccination. Chin Clin Oncol 6(2):19. https://doi.org/10.21037/cco.2017.02.04
Scheiblhofer S, Thalhamer J, Weiss R (2018) DNA and mRNA vaccination against allergies. Pediatr Allergy Immunol 29(7):679–688. https://doi.org/10.1111/pai.12964
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Meyer, C.U., Zepp, F. (2022). Principles in Immunology for the Design and Development of Vaccines. In: Thomas, S. (eds) Vaccine Design. Methods in Molecular Biology, vol 2410. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1884-4_2
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1884-4_2
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1883-7
Online ISBN: 978-1-0716-1884-4
eBook Packages: Springer Protocols